Shocking inequalities experienced by men with learning disabilities when diagnosed with prostate cancer have been highlighted ...

A new partnership will create a theranostics health care platform in the region with radiopharmaceutical production and therapy, molecular imaging, and clinical trials all at the same location. One ...

Forrest went on to reveal additional details, confirming that he was diagnosed with prostate cancer in 2024. According to him, he chose not to share much about his health publicly in the past years to ...

Comprehensive review of recent milestones highlights statistically significant efficacy in prostate cancer prevention, discovery of novel lipid-modulating properties, and the execution of high-value ...

Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated ...

Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy (ADT), the disease often progresses to castration-resistant prostate cancer ...

Johnson & Johnson's Akeega is opening new fronts in prostate cancer treatment with a fresh FDA approval, making it the first precision medicine combo for patients with BRCA2-mutated metastatic ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...

A teenage girl who spent her final years advocating for young people battling cancer is forever memorialized in history, thanks to a key bill passed by the House of Representatives. Mikaela Naylon was ...